Recall two batches of RINOFED PLUS TAB
2024-07-14
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer RINOFED PLUS TAB PARACETAMOL,PSEUDOEPHEDRINE HYDROCHLORIDE,TRIPROLIDINE 80-334-02 4209 4210 Jazeera Pharmaceutical Industries (JPI)
<p><span><span>Saudi FDA has issued a recall of two batches of </span></span><span><span>RINOFED PLUS </span></span><span><span>TAB due to out of specification result that was obtained during stability monitoring of the product. </span></span><span><span>Jazeera Pharmaceutical Industries (JPI) is</span></span><span><span> voluntarily recalling this batches.</span></span></p>
<p><span><span><strong><span>For healthcare professionals: </span></strong><span>Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.</span></span></span></p>
<p><span><span><strong><span>For patients,</span></strong></span></span></p>
<ol>
<li><span><span><span>Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.</span></span></span></li>
<li><span><span><span>Contact the recalling firm or SFDA if you have any questions about the recall.</span></span></span></li>
<li><span><span>Adverse reactions or quality problems experienced with the use of this product may be reported to </span></span><span><span><a href="https://ade.sfda.gov.sa/"><span>Saudi Vigilance</span></a></span></span><span><span> either online or call center (Call 19999).</span></span></li>
</ol>
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.